| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,125,711 | |||
| Prepaid expenses | 126,855 | |||
| Total current assets | 1,252,566 | |||
| Property and equipment, net | 6,787,456 | |||
| Intangible assets, total | 458,954 | |||
| Less accumulated amortization | 143,983 | |||
| Intangible assets, net | 314,971 | |||
| Service agreements | 2,087 | |||
| Total assets | 8,357,080 | |||
| Accounts payable-Nonrelated Party | 254,943 | |||
| Accounts payable-Related Party | 901,143 | |||
| Accrued expenses | 26,300 | |||
| Total current liabilities | 1,182,386 | |||
| Series a convertible preferred stock, 0.00001 par value, 10,000,000 shares designated, 916,308 and 905,717 shares issued and outstanding, at september 30, 2025 and june 30, 2025, respectively-Series AConvertible Preferred Stock | 9 | |||
| Common stock, 0.00001 par value 150,000,000 shares authorized, 17,566,079 and 16,606,832 shares issued and outstanding, at september 30, 2025 and june 30, 2025, respectively | 176 | |||
| Additional paid-in capital | 157,801,428 | |||
| Accumulated deficit | -150,626,919 | |||
| Total stockholders' equity | 7,174,694 | |||
| Total liabilities and stockholders' equity | 8,357,080 | |||
NANOVIRICIDES, INC. (NNVC)
NANOVIRICIDES, INC. (NNVC)